Blog Articles

There enormous growth in perinatal stem cell research, particularly the non-haematological uses of both cord blood and cord tissue stem cells.

Our Netcells team is proud to announce that we have released a second unit of umbilical cord blood belonging to a three-year-old Netcells baby born with cerebral palsy. 

Expectant parents are faced with a number of decisions before the birth of a baby, among them whether to collect the baby’s umbilical cord blood at birth.

Next Biosciences will work closely with CHOC to ensure that any unutilised funds from procedural fees donated by obstetricians will be directed to CHOC, as the Netcells ‘Families of Hope’ programme’s goals are closely aligned to theirs: Keeping more than hope alive.

Winner of first South African Global Impact Competition presents an innovative concept to address HIV/AIDS.

Children with cerebral palsy can now be treated with sibling cord blood therapy.